New York Life Investment Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.49M Sell
28,867
-573
-2% -$50.2K 0.02% 521
2026
Q1
$2.66M Buy
29,440
+692
+2% +$63.5K 0.02% 478
2025
Q4
$2.59M Sell
28,748
-168
-0.6% -$15.9K 0.02% 475
2025
Q3
$2.85M Sell
28,916
-725
-2% -$71.8K 0.03% 465
2025
Q2
$2.7M Buy
29,641
+7
+0% +$677 0.03% 471
2025
Q1
$3.35M Sell
29,634
-251
-0.8% -$26.9K 0.03% 409
2024
Q4
$3.16M Sell
29,885
-327
-1% -$35.1K 0.03% 436
2024
Q3
$3.26M Sell
30,212
-1,221
-4% -$133K 0.03% 447
2024
Q2
$3.41M Sell
31,433
-117
-0.4% -$13.8K 0.03% 426
2024
Q1
$4.16M Sell
31,550
-1,104
-3% -$138K 0.04% 384
2023
Q4
$3.97M Sell
32,654
-28
-0.1% -$3.12K 0.04% 374
2023
Q3
$3.67M Sell
32,682
-113
-0.3% -$14.3K 0.04% 363
2023
Q2
$4.77M Buy
32,795
+2,829
+9% +$384K 0.05% 323
2023
Q1
$3.87M Buy
29,966
+80
+0.3% +$10K 0.04% 366
2022
Q4
$3.81M Sell
29,886
-1
-0% -$116 0.04% 378
2022
Q3
$3.13M Buy
29,887
+71
+0.2% +$7.79K 0.04% 412
2022
Q2
$3.13M Buy
+29,816
New +$3.54M 0.04% 404

Other funds holding ZBH

New York Life Investment Management's ZBH Position: Q2 2026 in Review

New York Life Investment Management reduced its Zimmer Biomet (ZBH) stake by 1.9% in Q2 2026, selling an estimated $50.2K and leaving 28,867 shares worth $2.49M. The position accounts for 0.02% of the portfolio, ranked #521.

New York Life Investment Management first reported a position in ZBH in Q2 2022 and has held it in 17 quarters since. The position peaked at $4.77M in Q2 2023. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • New York Life Investment Management held 28,867 shares of Zimmer Biomet worth $2.49M as of Q2 2026.
  • New York Life Investment Management sold 573 Zimmer Biomet shares in Q2 2026, an estimated $50.2K.
  • Zimmer Biomet made up 0.02% of New York Life Investment Management's portfolio in Q2 2026, its #521 holding.
  • New York Life Investment Management first reported a position in Zimmer Biomet in Q2 2022 and has held it in 17 quarters since.
  • New York Life Investment Management's Zimmer Biomet position peaked at $4.77M in Q2 2023.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.